Link Bulk Drug Products Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 27-06-2024
- Paid Up Capital ₹ 0.50 M
as on 27-06-2024
- Company Age 36 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 7.50 M
as on 27-06-2024
- Revenue 738.78%
(FY 2022)
- Profit 824.63%
(FY 2022)
- Ebitda -105.55%
(FY 2022)
- Net Worth 14.96%
(FY 2022)
- Total Assets -47.82%
(FY 2022)
About Link Bulk Drug Products
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company has closed loans amounting to ₹7.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Tushar Shah and Madhuker Shah serve as directors at the Company.
- CIN/LLPIN
U24246MH1988PTC047699
- Company No.
047699
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jun 1988
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Link Bulk Drug Products?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tushar Shah  | Director | 23-Jan-1989 | Current |
| Madhuker Shah | Director | 23-Jan-1989 | Current |
Financial Performance and Corporate Structure Insights of Link Bulk Drug Products.
Link Bulk Drug Products Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 738.78% increase. The company also saw a substantial improvement in profitability, with a 824.63% increase in profit. The company's net worth Soared by an impressive increase of 14.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Link Bulk Drug Products?
In 2020, Link Bulk Drug Products had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Shri Arihant Co-Op Bank Ltd. Creation Date: 03 Jun 2000 | ₹4.25 M | Satisfied |
The Shamrao Vithal Co-Op. Bank Ltd. Creation Date: 10 Feb 2000 | ₹3.25 M | Satisfied |
How Many Employees Work at Link Bulk Drug Products?
Unlock and access historical data on people associated with Link Bulk Drug Products, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Link Bulk Drug Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Link Bulk Drug Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
